The DOI matches its Crossref record.
Prostate Cancer: Sextant Localization at MR Imaging and MR Spectroscopic Imaging before Prostatectomy—Results of ACRIN Prospective Multi-institutional Clinicopathologic Study
Open accessAbstract
PURPOSE: To determine the incremental benefit of combined endorectal magnetic resonance (MR) imaging and MR spectroscopic imaging, as compared with endorectal MR imaging alone, for sextant localization of peripheral zone (PZ) prostate cancer. MATERIALS AND METHODS: This prospective multicenter study, conducted by the American College of Radiology Imaging Network (ACRIN) from February 2004 to June 2005, was institutional review board approved and HIPAA compliant. Research associates were required to follow consent guidelines approved by the Office for Human Research Protection and established by the institutional review boards. One hundred thirty-four patients with biopsy-proved prostate adenocarcinoma and scheduled to undergo radical prostatectomy were recruited at seven institutions. T1-weighted, T2-weighted, and spectroscopic MR sequences were performed at 1.5 T by using a pelvic phased-array coil in combination with an endorectal coil. Eight readers independently rated the likelihood of the presence of PZ cancer in each sextant by using a five-point scale-first on MR images alone and later on combined MR-MR spectroscopic images. Areas under the receiver operating characteristic curve (AUCs) were calculated with sextant as the unit of analysis. The presence or absence of cancer at centralized histopathologic evaluation of prostate specimens was the reference standard. Reader-specific receiver operating characteristic curves for values obtained with MR imaging alone and with combined MR imaging-MR spectroscopic imaging were developed. The AUCs were estimated by using Mann-Whitney statistics and appropriate 95% confidence intervals. RESULTS: Complete data were available for 110 patients (mean age, 58 years; range, 45-72 years). MR imaging alone and combined MR imaging-MR spectroscopic imaging had similar accuracy in PZ cancer localization (AUC, 0.60 vs 0.58, respectively; P > .05). AUCs for individual readers were 0.57-0.63 for MR imaging alone and 0.54-0.61 for combined MR imaging-MR spectroscopic imaging. CONCLUSION: In patients who undergo radical prostatectomy, the accuracy of combined 1.5-T endorectal MR imaging-MR spectroscopic imaging for sextant localization of PZ prostate cancer is equal to that of MR imaging alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]Pyruvate
Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., Larson, P. E. Z., Harzstark, A. L., Ferrone, M., van Criekinge, M., Chang, J. W., Bok, R., Park, I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006070 · Cited by 1,286
Self-citationDickinson, L., Ahmed, H. U., Allen, C., Barentsz, J. O., Carey, B., Futterer, J. J., Heijmink, S. W., Hoskin, P. J., Kirkham, A., Padhani, A. R., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.12.009 · Cited by 737
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Hoeks, C. M. A., Barentsz, J. O., Hambrock, T., Yakar, D., Somford, D. M., Heijmink, S. W. T. P. J., Scheenen, T. W. J., Vos, P. C., Huisman, H., van Oort, I. M., et al. (2011) · Radiology · doi:10.1148/radiol.11091822 · Cited by 677
Eiber, M., Herrmann, K., Calais, J., Hadaschik, B., Giesel, F. L., Hartenbach, M., Hope, T., Reiter, R., Maurer, T., Weber, W. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198119 · Cited by 626
“To describe the anatomic distribution of intraprostatic tumor extension and to facilitate a straightforward correlation between imaging and histopathology (6,37), information on prostate involvement is described on a sextant basis (Table 3).”
BackgroundRosenkrantz, A. B., Kim, S., Lim, R. P., Hindman, N., Deng, F.-M., Babb, J. S., & Taneja, S. S. (2013) · Radiology · doi:10.1148/radiol.13122233 · Cited by 267
White, N. S., McDonald, C. R., Farid, N., Kuperman, J., Karow, D., Schenker-Ahmed, N. M., Bartsch, H., Rakow-Penner, R., Holland, D., Shabaik, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3534 · Cited by 255
A urologist’s perspective on prostate cancer imaging: past, present, and future
George, A. K., Turkbey, B., Valayil, S. G., Muthigi, A., Mertan, F., Kongnyuy, M., & Pinto, P. A. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0751-6 · Cited by 30
Metadata
- Authors
- Weinreb, J. C., Blume, J. D., Coakley, F. V., Wheeler, T. M., Cormack, J. B., Sotto, C. K., Cho, H., Kawashima, A., Tempany-Afdhal, C. M., Macura, K. J., Rosen, M., Gerst, S. R., & Kurhanewicz, J.
- Venue
- Radiology
- Published
- 2009-04
- Volume
- 251
- Issue
- 1
- Pages
- 122-133
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2110394359
- Cited by
- 237
- References
- 0
- FWCI
- 23.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.